E-QURE CORP. (OTCMKTS:EQUR) Files An 8-K Other Events

E-QURE CORP. (OTCMKTS:EQUR) Files An 8-K Other Events
Item 8.01 Other Events

Story continues below

On February 20, 2017, E-Qure Corp. (the "Registrant") received the official certification from the Israeli Ministry of Health authorizing the use of the Registrant’s BST Device in Israel. The BST Device implements patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure.


About E-QURE CORP. (OTCMKTS:EQUR)

E-Qure Corp. owns intellectual property (IP) of technology of wound healing device. The IP assets, including the wound healing device, are designed for wound treatment incorporating Bioelectrical Signal Therapy (BST Device). The BST Device implements electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The BST Device, using electrodes affixed around the opposing sides of the wound, emits an electrical field around the wound and therefore mimics the electrochemical physiology principle and induces local cell regeneration. The BST Device is used to treat severe stage II, as well as stage III and IV wounds, including pressure ulcers, diabetic ulcers and venous ulcers. The BST Device is a device for adjunctive therapy in wound healing. The BST Device is able to automatically adjust the electric pulse amplitude based on a patient’s impedance reading.

E-QURE CORP. (OTCMKTS:EQUR) Recent Trading Information

E-QURE CORP. (OTCMKTS:EQUR) closed its last trading session down -0.040 at 0.260 with 60,823 shares trading hands.

An ad to help with our costs